Isolated systolic hypertension
primary care practice patterns in a Nigerian high-risk subpopulation
Keywords:
Hypertension, Primary health care, Blood pressure, Ambulatory blood pressure monitoring, SystoleAbstract
CONTEXT AND OBJECTIVE: Hypertension man- agement and risk prediction based on diastolic blood pressure may be of little value for older people and people with isolated systolic hyper- tension (ISH). This study investigated primary care practice patterns in ISH management in a Nigerian high-risk subpopulation. DESIGN AND SETTING: Three-year retrospective cohort review of outpatient medical records at a state primary health care facility in south- western Nigeria. METHODS: ISH was defined according to international guidelines. Treatments were graded as relatively non-aggressive, mildly aggressive and moderately aggressive. Data were collected using a data abstraction form and statistically analyzed. RESULTS: The drug/regimen choice controlled systolic blood pressure (SBP) in only 46.90% of the population after the first visit to the clinic. SBP control among treated patients was significantly inadequate. Group mean SBP was consistently > 150 mmHg in 28.13% of the patients for six weeks after enrollment and for at least two addi- tional visits. Data analysis revealed an increasing tendency to place patients on monotherapy or “no drug treatment” with successive visits to the clinic, even in cases of uncontrolled systolic blood pressure, as well as declining prescription of moderately aggressive combination therapy. CONCLUSION: Aggressive ISH management needs to be further emphasized at primary care levels, which for many low-income patients may be the first and last orthodox port of call.
Downloads
References
O’Rourke M, Frohlich ED. Pulse pressure: Is this a clinically useful risk factor? Hypertension. 1999;34(3):372-4.
Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72.
Simon AC, Safar MA, Levenson JA, Kheder AM, Levy BI. Systolic hypertension: hemodynamic mechanism and choice of antihypertensive treatment. Am J Cardiol. 1979;44(3):505-11.
Messerli FH. Essential hypertension in the elderly. Triangle. 1985;24:35-47.
Messerli FH, Sundgaard-Riise K, Ventura HO, Dunn FG, Glade LB, Frohlich ED. Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet. 1983;2(8357):983-6.
Grassi G, Seravalle G, Bertinieri G, et al. Sympathetic and reflex alterations in systo-diastolic and systolic hypertension of the elderly. J Hypertens. 2000;18(5):587-93.
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157(21):2413-46.
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999;17(2):151-83.
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265(24):3255-64.
Staessen JA, Fagard R, Thijs L, et al. Randomised double- blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hy- pertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350(9080):757-64.
Cooper R, Rotimi C, Ataman S, et al. The prevalence of hy- pertension in seven populations of west African origin. Am J Public Health. 1997;87(2):160-8.
Bovet P, Ross AG, Gervasoni JP, et al. Distribution of blood pressure, body mass index and smoking habits in the urban population of Dar es Salaam, Tanzania, and associations with socioeconomic status. Int J Epidemiol. 2002;31(1):240-7.
Cappuccio FP, Micah FB, Emmett L, et al. Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension. 2004;43(5):1017-22.
Erhun WO, Olayiwola G, Agbani EO, Omotosho NS. Prevalence of Hypertension in a University Community in South West Nigeria. African Journal of Biomedical Research. 2005;8(1):15-9. Available from URL: http://www.bioline.org. br/abstract?id=md05002&lang=en. Accessed in 2006 (Jan 27).
Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens. 1990;8(5):393-405.
Himmelmann A, Hedner T, Hansson L, O’Donnell CJ, Levy
D. Isolated systolic hypertension: an important cardiovascular risk factor. Blood Pressure. 1998;7(4):197-207.
Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham study. Circulation. 1980;61(6):1179-82.
Curb JD, Borhani NO, Entwisle G, et al. Isolated systolic hyperten- sion in 14 communities. Am J Epidemiol. 1985;121(3):362-70.
Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152(1):56-64.
Black HR. Individualized selection of antihypertensive drug therapy for older patients. Am J Hypertens. 1998;11(3 Pt 2):62S-7S.
Heesen WF, Beltman FW, May JF, et al. High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey. Hypertension. 1997;29(2):539-43.
Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114(5):345-52.
Hyman DJ, Pavlik VN, Vallbona C. Physician Role in Lack of Awareness and Control of Hypertension. J Clin Hypertens (Greenwich). 2000;2(5):324-30.
Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate manage- ment of blood pressure in a hypertensive population. N Engl J Med. 1998;339(27):1957-63.
Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289(19):2534-44.
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-97.
